For the Inventor, By the Inventor

Enter assignee name

Kenilworth, NJ, United States of America

Smartcells, Inc.

USPTO Granted Patents = 19

CIPO Patents = 6

EPO Patents = 2

Forward Citations = 96

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Todd C Zion (19 out of 47 patents)

Thomas M Lancaster (19 out of 45 patents)

Wenyi Cai (2 out of 2 patents)

4. Ryan Faucette (2 out of 2 patents)

5. Matthew Pecukonis (2 out of 2 patents)

6. Sylaja Murikipudi (1 out of 3 patents)

7. Rassol Laleau (1 out of 1 patent)

8. Robert Butters (1 out of 1 patent)

9. Naomi Choodnovskiy (1 out of 1 patent)

10. Zhiyu Chen (1 out of 1 patent)

11. Matthew Nalewanski (1 out of 1 patent)

19 patents: Sort by Forward Citations

1. 10398781 - Conjugate based systems for controlled drug delivery (2019-09-03),

2. 9745355 - Binding-site modified lectins and uses thereof (2017-08-29),

3. 9579391 - Conjugate based systems for controlled drug delivery (2017-02-28),

4. 9463249 - Crystalline insulin-conjugates (2016-10-11),

5. 9265838 - Conjugate based systems for controlled drug delivery (2016-02-23),

6. 9114176 - Exogenously triggered controlled release materials and uses thereof (2015-08-25),

7. 9095623 - Terminally-functionalized conjugates and uses thereof (2015-08-04),

8. 9074015 - Recombinantly expressed insulin polypeptides and uses thereof (2015-07-07),

9. 9068013 - Recombinant lectins, binding-site modified lectins and uses thereof (2015-06-30),

10. 9050370 - Conjugate based systems for controlled drug delivery (2015-06-09),

11. 8933207 - Drug-ligand conjugates, synthesis thereof, and intermediates thereto (2015-01-13),

12. 8906850 - Crystalline insulin-conjugates (2014-12-09),

13. 8846103 - Exogenously triggered controlled release materials and uses thereof (2014-09-30),

14. 8729242 - Methods for reducing the mitogenicity of lectin compositions (2014-05-20),

15. 8697643 - Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the local concentration of an indicator (2014-04-15),

SMARTCELLS, INC. is a leading biotechnology company specializing in stem cell research and therapeutics. With a focus on developing innovative cell-based products and therapies, we aim to transform the future of regenerative medicine. Our dedicated team of scientists and researchers work tirelessly to discover groundbreaking stem cell technologies to improve and enhance patient outcomes. Visit our website to learn more about our cutting-edge advancements in the field of stem cell research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

19 Patents

#4 in Kenilworth, NJ

#643 in New Jersey

#16,575 in US

#31,645 in the World

Kenilworth, NJ, United States of America

Smartcells, Inc.

Forward Citations = 96

13 inventors:

Todd C Zion (19 out of 47 patents)

Thomas M Lancaster (19 out of 45 patents)

Wenyi Cai (2 out of 2 patents)

4. Ryan Faucette (2 out of 2 patents)

5. Matthew Pecukonis (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…